Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601

Mingzhang Gao, Min Wang, Barbara Glick-Wilson, Jill Meyer, Jonathan Peters, Paul Territo, Mark Green, Gary Hutchins, Hamideh Zarrinmayeh and Qi-Huang Zheng
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 181;
Mingzhang Gao
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Wang
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Glick-Wilson
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Meyer
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Peters
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Territo
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Green
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Hutchins
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamideh Zarrinmayeh
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi-Huang Zheng
1Indiana University School of Medicine Indianapolis IN United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

181

Objectives: The purinergic receptor subtype 7 (P2X7R) is a novel molecular imaging target for neuroinflammation via PET. We have previously developed [11C]GSK1482160 as a promising P2X7R radioligand for imaging neuroinflammation. Here we report the synthesis and preliminary biological evaluation of a new P2X7R radioligand [18F]IUR-1601.

Methods: The reference standard IUR-1601 ((S)-N-(2-chloro-3-(trifluoromethyl)benzyl)-1-(2-fluoroethyl)-5-oxopyrrolidine-2-carboxamide) and its corresponding precursor (S)-N-(2-chloro-3-(trifluoromethyl)benzyl)-1-(2-chloroethyl)-5-oxopyrrolidine-2-carboxamide were synthesized from tert-butyl (S)-5-oxopyrrolidine-2-carboxylate, fluoroethylbromide and chloroethylbromide, and 2-chloro-3-(trifluoromethyl)benzylamine. Another labeling precursor desmethyl-GSK1482160 was prepared from L-pyroglutamic acid and 2-chloro-3-(trifluoromethyl)benzylamine. One-step radiosynthesis of [18F]IUR-1601 from chloroethyl- precursor was first conducted and failed. Therefore, [18F]IUR-1601 was synthesized from desmethyl-GSK1482160 with [18F]FCH2CH2OTs, prepared from TsOCH2CH2OTs and K[18F]F/Kryptofix2.2.2, in two steps. The potency of IUR-1601 in comparison with GSK1482160 was determined by a ligand competitive binding assay using [11C]GSK1482160. Results : The overall chemical yields for IUR-1601 and its chloroethyl- precursor were 10-15% in 3 steps. The yield of desmethyl-GSK1482160 was 76% in 1 step. IUR-1601 and its chloroethyl- precursor are unstable under high temperature and strong base conditions, converting to (S)-N-(2-chloro-3-(trifluoromethyl)benzyl)-5-oxo-1-vinylpyrrolidine-2-carboxamide by elimination reaction, which caused one-step synthesis of [18F]IUR-1601 to fail. In addition, [18F]fluoroethylation of amide requires high reaction temperature and strong base, thus both result in that radiochemical yield for two-step synthesis of [18F]IUR-1601 was very low, 1-3%. The radiochemical purity was >99%, and the specific activity was >2 Ci/µmol at EOB determined by a “spike”

Methods: The binding affinity Ki for IUR-1601 and GSK1482160 is 4.3 and 5.1 nM, respectively. Conclusions : A new P2X7R radioligand [18F]IUR-1601 has been successfully radiosynthesized, and retains the P2X7R affinity of [11C]GSK1482160. The radiosynthesis optimization, automation and in vivo biological evaluation of [18F]IUR-1601 are currently underway. Research Support : Showalter Young Investigator Award and Indiana University Department of Radiology and Imaging Sciences.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
Mingzhang Gao, Min Wang, Barbara Glick-Wilson, Jill Meyer, Jonathan Peters, Paul Territo, Mark Green, Gary Hutchins, Hamideh Zarrinmayeh, Qi-Huang Zheng
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 181;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
Mingzhang Gao, Min Wang, Barbara Glick-Wilson, Jill Meyer, Jonathan Peters, Paul Territo, Mark Green, Gary Hutchins, Hamideh Zarrinmayeh, Qi-Huang Zheng
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 181;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Novel Radiochemistry I

  • Methods for labeling the trifluoroacetyl group with carbon-11 or fluorine-18 exemplified by the preparation of [18F/11C]2,2,2-trifluoro-1-phenylethanone
  • Exploration of alcohol-enhanced Cu-mediated radiofluorination towards practical labeling
Show more Novel Radiochemistry I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire